Inventor
STARKE INGEMAR
SE58 patents
⚠️ This page may combine multiple inventors who share the name “STARKE INGEMAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALBIREO AB
32 patentsUS10487111B2Nov 26, 2019
IBAT inhibitors for the treatment of liver diseases
ALBIREO AB23 citations98
US10093697B2Oct 9, 2018
IBAT inhibitors for the treatment of liver diseases
ALBIREO AB25 citations98
US10011633B2Jul 3, 2018
IBAT inhibitors for the treatment of liver diseases
ALBIREO AB20 citations98
US9694018B1Jul 4, 2017
IBAT inhibitors for the treatment of liver disease
ALBIREO AB47 citations98
US9688720B2Jun 27, 2017
IBAT inhibitors for the treatment of liver diseases
ALBIREO AB27 citations98
US11572350B1Feb 7, 2023
Benzothia(di)azepine compounds and their use as bile acid modulators
ALBIREO AB17 citations95
US11225466B2Jan 18, 2022
Benzothiadiazepine compounds and their use as bile acid modulators
ALBIREO AB23 citations95
US11732006B2Aug 22, 2023
IBAT inhibitors for the treatment of liver diseases
ALBIREO AB11 citations94
US11267794B2Mar 8, 2022
Benzothia(di)azepine compounds and their use as bile acid modulators
ALBIREO AB21 citations94
US11261212B2Mar 1, 2022
IBAT inhibitors for the treatment of liver diseases
ALBIREO AB17 citations94
US11180465B2Nov 23, 2021
Benzothia(di)azepine compounds and their use as bile acid modulators
ALBIREO AB25 citations94
US11111224B2Sep 7, 2021
Benzothia(di)azepine compounds and their use as bile acid modulators
ALBIREO AB30 citations94
US11014898B1May 25, 2021
Benzothiazepine compounds and their use as bile acid modulators
ALBIREO AB30 citations94
US10981952B2Apr 20, 2021
IBAT inhibitors for the treatment of liver diseases
ALBIREO AB20 citations94
US10975045B2Apr 13, 2021
Benzothiazepine compounds and their use as bile acid modulators
ALBIREO AB23 citations94
US10941127B2Mar 9, 2021
Benzothiadiazepine compounds and their use as bile acid modulators
ALBIREO AB28 citations94
US10793534B2Oct 6, 2020
Benzothia(di)azepine compounds and their use as bile acid modulators
ALBIREO AB21 citations94
US10000528B2Jun 19, 2018
IBAT inhibitors for the treatment of liver diseases
ALBIREO AB18 citations94
US10221212B2Mar 5, 2019
IBAT inhibitors for the treatment of liver diseases
ALBIREO AB11 citations92
US12187812B2Jan 7, 2025
IBAT inhibitors for the treatment of liver diseases
ALBIREO AB3 citations86
US11891368B2Feb 6, 2024
Benzothia(di)azepine compounds and their use as bile acid modulators
ALBIREO AB10 citations86
US11708340B2Jul 25, 2023
Benzothia(di)azepine compounds and their use as bile acid modulators
ALBIREO AB12 citations86
US11377429B2Jul 5, 2022
Benzothia(di)azepine compounds and their use as bile acid modulators
ALBIREO AB13 citations86
US11773071B2Oct 3, 2023
Benzothiazepine compounds and their use as bile acid modulators
ALBIREO AB14 citations85
US11603359B2Mar 14, 2023
Benzothiadiazepine compounds and their use as bile acid modulators
ALBIREO AB11 citations85
US11306064B2Apr 19, 2022
Benzothia(di)azepine compounds and their use as bile acid modulators
ALBIREO AB17 citations85
US12365658B2Jul 22, 2025
Benzothia(di)azepine compounds and their use as bile acid modulators
ALBIREO AB2 citations75
US12202809B2Jan 21, 2025
Benzothia(di)azepine compounds and their use as bile acid modulators
ALBIREO AB4 citations75
US12134606B2Nov 5, 2024
Benzothia(di)azepine compounds and their use as bile acid modulators
ALBIREO AB5 citations75
US12060338B2Aug 13, 2024
Benzothia(di)azepine compounds and their use as bile acid modulators
ALBIREO AB5 citations75
US12024495B2Jul 2, 2024
Benzothiazepine compounds and their use as bile acid modulators
ALBIREO AB5 citations75
US12187690B2Jan 7, 2025
Benzothiadiazepine compounds and their use as bile acid modulators
ALBIREO AB4 citations74
ASTRAZENECA AB
16 patentsUS7226943B2Jun 5, 2007
Benzothiepine ileal bile acid transport inhibitors
ASTRAZENECA AB80 citations97
US7125864B2Oct 24, 2006
Benzothiazepine derivatives for the treatment of hyperlipidemia
ASTRAZENECA AB86 citations97
US7192946B2Mar 20, 2007
Benzothiazepine derivatives
ASTRAZENECA AB87 citations96
US7238684B2Jul 3, 2007
Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
ASTRAZENECA AB93 citations95
US7192947B2Mar 20, 2007
Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions
ASTRAZENECA AB74 citations95
US7192945B2Mar 20, 2007
Benzothiazepine derivatives
ASTRAZENECA AB85 citations95
US7132416B2Nov 7, 2006
Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemia
ASTRAZENECA AB90 citations95
US6906058B2Jun 14, 2005
1,5-Benzothiazepines and their use as hypolipidaemics
ASTRAZENECA AB108 citations94
US6518270B1Feb 11, 2003
Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
ASTRAZENECA AB29 citations92
US6313136B1Nov 6, 2001
Imidazo pyridine derivatives which inhibit gastric acid secretion
ASTRAZENECA AB30 citations92
US6313137B1Nov 6, 2001
Imidazo pyridine derivatives which inhibit gastric acid secretion
ASTRAZENECA AB29 citations92
US6265415B1Jul 24, 2001
Compounds for inhibition of gastric acid secretion
ASTRAZENECA AB18 citations92
US6613775B1Sep 2, 2003
Imidazo[1,2-a]pyridine compounds
ASTRAZENECA AB13 citations83
US6465505B1Oct 15, 2002
Benzyl-substituted benzimidazoles
ASTRAZENECA AB14 citations83
US7470678B2Dec 30, 2008
Diphenylazetidinone derivatives for treating disorders of the lipid metabolism
ASTRAZENECA AB18 citations81
US6579884B1Jun 17, 2003
Compounds
ASTRAZENECA AB11 citations73
STARKE INGEMAR
1 patentASTRA AB
1 patentShowing the top 50 of 58 patents by PatentIndex Score.